ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is Magnesium the Missing Link in Your Heart Healthy Routine?

Why the Mediterranean Diet Is so Successful

A Little Zinc Goes a Long Way

Supplementation with vitamin D associated with improved testosterone, erectile function among middle...

Vitamin D deficiency increases risk of chronic headache

Wearable biosensors can flag illness, Lyme disease, risk for diabetes; low airplane oxygen

VIDEO: The Best Brain Foods That Help Increase Your Memory!

More evidence for calorie restriction’s longevity effect

Iron (And More) For Lasting, Natural Energy

Affordable Care Act made cancer screening more accessible for millions, study finds

 
Print Page
Email Article

First objective diagnostic test for Parkinson’s, rolling out at 14 US medical centers

  [ 28 votes ]   [ Discuss This Article ]
www.ProHealth.com • August 25, 2011


Researchers report on the first objective diagnostic test for Parkinson’s disease – a brain function imaging agent that allows SPECT scans to depict dopamine activity in the brain and will be trialed at 14 medical centers, which are enrolling now.

Parkinson’s disease, a type of nerve degeneration associated with loss of dopamine in the brain, involves gradual development of serious tremors, stiffness, and balance problems, and claims some 60,000 new cases each year in the US.

Unfortunately, diagnosis of PD has been notoriously hard to pin down versus other movement disorders such as essential tremor (which require different treatments). In fact, examinations early on can be inconclusive or lead to misdiagnosis of another movement disorder, and doctors have not even been able to say with certainty that those enrolled in Parkinson's studies have the disease, says Tanya Simuni, MD, a neurologist at Northwestern Memorial Hospital’s Parkinson's Disease and Movement Disorders Center. So diagnosis can take up to 6 years.

This is because "in Parkinson's patients the brain's anatomy remains largely normal, unlike other conditions such as stroke, where damage to the brain is visible," she explains.

But now, thanks to a new diagnostic imaging technique that Dr. Simuni and her team are employing at Northwestern, there is an objective test to evaluate patients for “Parkinsonian syndromes,” such as Parkinson's disease. Northwestern is among the first institutions in the country to offer DaTscan™, the only FDA-approved imaging agent for assessment of movement disorders.

"The scan by itself does not make the diagnosis of Parkinson's but it allows us to identify patients who have loss of dopamine, the major chemical responsible for the symptoms, from those who have no dopamine deficiency," says Dr. Simuni, MD. "This is a very important step in being able to accurately identify and treat movement disorders and hopefully allow us to better understand these diseases over time."

Developed by GE Healthcare, DaTscan is a substance used to detect the presence of dopamine transporters (DaT) in the brain. A patient is injected with the contrast agent and then undergoes a single-photon emission computed tomography (SPECT) scan.

The test captures detailed pictures of the brain's dopamine system and can provide visual evidence of the presence of dopamine transporters.

• Scans of patients with Parkinson's disease or another parkinsonian syndrome will show very low dopamine levels.

• A SPECT scan examines brain function, rather than structure, and can show change in the brain's chemistry.

• The injected "DaTscan attaches to dopamine neurons which illuminate on the SPECT scan,” says Dr. Simuni. “The more light areas that exist, the more healthy dopamine brain cells remain.

• If the areas of the brain that should show dopamine remain dark, it may indicate the patient has some type of parkinsonian syndrome."

"We are hopeful that this will lead to improved quality of life for these patients with better long term outcomes, as well as protection from unnecessary treatments initiated because of misdiagnosis," says Dr. Simuni.

And while she does not believe it is necessary for every patient to confirm their Parkinson's diagnosis with DaTscan, she does see it as a valuable tool for patients with uncertain syndromes, or those who have not responded to treatment. She also sees it as a means for improving Parkinson's research by ensuring those enrolled in studies actually have the disease.

DaTscan is already being used by the Michael J. Fox Foundation for its landmark biomarkers study - the Parkinson's Progression Markers Initiative (PPMI) - to validate that the subjects have Parkinson's disease. Northwestern is one of the 14 U.S. medical centers enrolling for the PPMI, which is among the first clinical trials using DaTscan in this way.

Source: Northwestern Memorial Hospital (Chicago) news release, Aug 25, 2011




Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Ultra ATP+, Double Strength Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Green Coffee Extract: Unique Obesity Intervention Green Coffee Extract: Unique Obesity Intervention
Complete and Natural Menopause Relief Complete and Natural Menopause Relief
Coenzyme Q10 - The Energy Maker Coenzyme Q10 - The Energy Maker
How to Jump-start and Sustain Energy Production in CFS How to Jump-start and Sustain Energy Production in CFS
The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map